FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/074449 [Registered on: 26/09/2024] Trial Registered Prospectively
Last Modified On: 25/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Evaluation of Dhanwantar Ghritam in Guda Arsha 
Scientific Title of Study   Clinical evaluation of Dhanwantar Ghritam Matra Basti in Guda Arsha Haemorrhoids  
Trial Acronym  ARSH 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Tejas Mishra  
Designation  Pg Scholar 
Affiliation  Quadra Institute of Ayurveda and Hospital 
Address  Opd No 1 Department of Shalya Tantra Quadra Institute of Ayurveda and Hospital Nh58 Roorkee Haridwar Road Near Montfort School Roorkee 247667

Hardwar
UTTARANCHAL
247667
India 
Phone  9557940036  
Fax    
Email  tejasmishra3@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Saurabh Kumar 
Designation  Professor 
Affiliation  Quadra Institute of Ayurveda and Hospital 
Address  Opd No 1 Department of Shalya Tantra Quadra Institute of Ayurveda and Hospital Nh58 Roorkee Haridwar Road Near Montfort School Roorkee 247667

Hardwar
UTTARANCHAL
247667
India 
Phone  9717944844  
Fax    
Email  deardrsaurabh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Tejas Mishra  
Designation  Pg Scholar 
Affiliation  Quadra Institute of Ayurveda and Hospital 
Address  Opd No 1 Department of Shalya Tantra Quadra Institute of Ayurveda and Hospital Nh58 Roorkee Haridwar Road Near Montfort School Roorkee 247667

Hardwar
UTTARANCHAL
247667
India 
Phone  9557940036  
Fax    
Email  tejasmishra3@gmail.com  
 
Source of Monetary or Material Support  
Quadra Institute of Ayurveda Opd No 1 Department of Shalya Tantra Quadra Institute of Ayurveda and Hospital Nh58 Roorkee Haridwar Road Near Montfort School Roorkee, Hardwar, Uttaranchal, India 247667 
 
Primary Sponsor  
Name  Tejas Mishra 
Address  Opd No 1 Department of Shalya Tantra Quadra Institute of Ayurveda and Hospital Nh58 Roorkee Haridwar Road Near Montfort School Roorkee 247667 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Saurabh Kumar  Quadra Institute of Ayurveda And Hospital Roorkee  Opd No 1 Department of Shalya Tantra Quadra Institute of Ayurveda and Hospital Nh58 Roorkee Haridwar Road Near Montfort School Roorkee 247667 Hardwar Uttaranchal
Hardwar
UTTARANCHAL 
9717944844

deardrsaurabh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
QIA-IEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K641||Second degree hemorrhoids. Ayurveda Condition: ARSAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: Sushruta Samhita Chikitsathan 12, Procedure details: 1.The patient will be placed in Left lateral position. 2. Then 50 ml of lukewarm Dhanwantar Ghritam will be loaded in an enema syringe. A rubber catheter oleated with Ghritam will be attached to the enema syringe. 3. Catheter will be introduced through the anal orifice into the rectum in the direction parallel to the vertebral column. Dhanwantar Ghritam will be given via enema syringe. 4. The patient will be asked to take a deep breath and not to shake his body while introducing the drug. 5. The entry of Vayu inside the Guda will be avoided by leaving a little amount of Dhanwantar Ghritam.)
(1) Medicine Name: Dhanwantar Ghrita, Reference: Sushruta Samhita Chikitsathan 12, Route: Rectal, Dosage Form: Ghrita, Dose: 50(ml), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patient’s age ranging from 18 to 60 years.
2.The patients having complaints of I and II degree internal Hemorrhoids will be taken for the study after screening.
3.Patients willing to undergo trial and ready to give informed and written consent. 
 
ExclusionCriteria 
Details  1.Patients below the age of 18 years and above the age of 60 years.
2.Third degree prolapsed internal and external Haemorrhoids.
3.Pregnancy.
4.Congenital deformity.
5.Known case of Carcinoma and Tuberculosis.
6.Rectal prolapsed.
7.Patients suffering from other systemic diseases such as HIV, known case of Hepatitis B, Ulcerative colitis, Crohn’s disease, Cirrhosis of liver and Carcinoma of rectum will be excluded from this study.
8.Patient with uncontrolled DM and HTN.
9.External thrombosed Haemorrhoids.
10.The associated condition like Fistula-in-ano, Fissure-in-ano will be excluded from this study. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To help regress the growth of hemorrhoids further into 3rd and 4th degree.  28 days 
 
Secondary Outcome  
Outcome  TimePoints 
Provide a alternative and safe treatment for hemorrhoids.  18 months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   07/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is an open labelled clinical study to evaluate the effect of Dhanwantar Ghritam in Guda Arsha for the age group of 18 yeaars to 60 years for the duration of 28 days. 30 patients will be selected randomly irrespective of gender, race, religion, occupation. 

The clinical study aims to provide better safe and effective management to the patient of Guda Arsha.

Total 30 patients will be registered for this study from the OPD/IPD of surgery department of quadra institute of ayurveda, roorkee.

Patients will be assessed on the basis of subjective and objective parameters before and after treatment. Detailed proforma will be prepared on the basis of Ayurvedic and allied sciences.

Observation of patients will be done before, during and after completion of trial.

 


 
Close